- PR Newswire•yesterday
Sarissa Capital Files Presentation In Proxy Contest With Innoviva Highlighting Innoviva's Lack Of Shareholder Focus And Poor Corporate Governance
GREENWICH, Conn., March 27, 2017 /PRNewswire/ -- Sarissa Capital Management LP ("Sarissa") announced today that it filed a presentation with the Securities and Exchange Commission (the "SEC") in connection with its intent to nominate a minority slate to the Board of Directors of Innoviva, Inc. (INVA) ("Innoviva") at its 2017 annual meeting of stockholders to be held on April 20, 2017 at 8:30 a.m. EDT in Philadelphia, PA. The presentation is available on the SEC's website at http://www.sec.gov or on the website maintained by D.F. King & Co., Inc. at http://www.dfking.com/INVA. Innoviva oversees an extremely large amount of shareholder capital, every dollar of which must be utilized in a manner that enhances shareholder value. Sarissa strongly believes that Innoviva must learn that shareholder capital must be optimized for the benefit of shareholders instead of management.
- Business Wire•6 days ago
Innoviva, Inc. today announced that is has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming Annual Stockholder Meeting to be held on April 20, 2017 at 8:30 a.m.
- TheStreet.com•15 days ago
The healthcare activist fund says it's "perplexed" Innoviva chose a proxy fight rather than a deal over the company's direction.
INVA : Summary for INOVA TECHNOLOGY INC - Yahoo Finance
Innoviva, Inc. (INVA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||11.92 x 200|
|Ask||13.38 x 100|
|Day's Range||13.01 - 13.68|
|52 Week Range||8.67 - 14.15|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||24.83|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|